Microbial Identification Workflows: From Phenotypic to Molecular Methods

Microbial identification in clinical diagnostics follows a structured progression from simple phenotypic observations to complex molecular analyses. This article outlines a practical workflow for laboratory students, technicians, researchers, and diagnostic professionals, covering colony morphology, Gram stain, biochemical tests, MALDI-TOF mass spectrometry, and 16S rRNA sequencing. The goal is to provide a comparison framework for selecting identification methods based on laboratory resources and clinical needs.

Scope and Reader Context

Clinical microbiology laboratories face a common challenge: identifying microorganisms accurately, quickly, and within budget constraints. The choice of identification method depends on several factors including laboratory infrastructure, staff expertise, sample volume, clinical urgency, and available funding. This article serves laboratory students learning diagnostic workflows, technicians performing routine identifications, researchers designing identification protocols, and diagnostic professionals who must select appropriate methods for their settings.

The workflow described here moves from inexpensive, widely accessible phenotypic methods to advanced molecular techniques that require specialized equipment and training. Each method has distinct strengths and limitations that affect its suitability for different clinical scenarios. Understanding these tradeoffs helps laboratories make informed decisions about method selection and interpretation.

At a Glance: Method Comparison Table

Core Principles of Microbial Identification

Microbial identification rests on the principle that different species possess distinct characteristics that can be measured and compared against known references. These characteristics range from observable physical traits to molecular sequences. The identification process becomes more definitive as methods move from phenotypic observations to genotypic analysis.

Phenotypic methods examine expressed characteristics such as colony appearance, cellular morphology, metabolic activities, and biochemical reactions. These methods are inexpensive and accessible but can be limited by phenotypic variability within species and the need for pure cultures. Molecular methods examine genetic material directly, providing higher resolution and the ability to identify organisms that are difficult to culture.

The World Health Organization emphasizes that laboratory quality management systems are essential for reliable diagnostic results. The WHO Laboratory Quality Management System Handbook provides guidance on implementing quality practices that ensure accurate and reproducible identification results. Laboratories should integrate quality control measures at each step of the identification workflow.

Initial Assessment: Colony Morphology and Gram Stain

Colony Morphology Examination

The identification workflow begins with careful observation of colony characteristics on culture media. Colony morphology provides preliminary information that guides subsequent testing. Key features to record include size, shape, color, texture, elevation, margin characteristics, hemolytic patterns on blood agar, and any pigment production.

Colony morphology observations are most useful when performed systematically and documented consistently. Laboratories should establish standard criteria for describing colonies to ensure reproducibility across staff members. These observations narrow the range of possible organisms and help select appropriate biochemical tests or molecular methods.

Gram Stain Procedure and Interpretation

The Gram stain remains a fundamental step in bacterial identification. This differential stain separates bacteria into Gram-positive and Gram-negative groups based on cell wall structure. The procedure involves crystal violet staining, iodine mordanting, alcohol decolorization, and safranin counterstaining.

Gram-positive organisms retain the crystal violet stain and appear purple, while Gram-negative organisms lose the stain during decolorization and take up the safranin counterstain, appearing pink or red. Beyond the Gram reaction, the stain reveals cellular morphology including cocci, bacilli, spirilla, and arrangements such as clusters, chains, or pairs.

The Gram stain also provides information about sample quality and the presence of mixed populations. Organisms with atypical Gram reactions, such as those with damaged cell walls or certain genera like Mycobacteria, require additional considerations. The WHO Laboratory Biosafety Manual provides guidance on safe handling of specimens during staining procedures, emphasizing the importance of proper fixation and containment.

Limitations of Phenotypic Initial Assessment

Colony morphology and Gram stain results are presumptive and require confirmation through additional testing. Some organisms exhibit variable Gram reactions, and colony morphology can be influenced by culture conditions, media composition, and incubation time. Laboratories must recognize these limitations and avoid overinterpreting initial observations.

Biochemical Testing Methods

Traditional Biochemical Panels

Biochemical tests detect specific metabolic activities that characterize microbial species. Common tests include carbohydrate fermentation, enzyme production, amino acid utilization, and gas production. These tests are available as individual reagents, tubed media, or commercial panel systems that combine multiple tests in a single format.

Traditional biochemical identification relies on comparing an organism's reaction profile against established databases. The accuracy of this approach depends on the quality of the reference database and the consistency of test performance. Laboratories should use standardized procedures and appropriate quality control organisms to ensure reliable results.

Commercial Identification Systems

Commercial systems such as API strips, VITEK, and MicroScan automate or semi-automate biochemical testing. These systems offer standardized panels, automated reading, and computer-assisted interpretation. They reduce hands-on time and improve consistency compared to traditional tubed media methods.

The choice between traditional and commercial biochemical systems depends on laboratory volume, budget, and technical expertise. Commercial systems require ongoing reagent supplies and instrument maintenance but provide faster results and easier interpretation. Traditional methods offer flexibility and lower per-test costs but require more technical skill and interpretation experience.

Biochemical Testing Limitations

Biochemical identification has several inherent limitations. Phenotypic expression can vary with culture conditions, and some species show overlapping biochemical profiles that make differentiation difficult. Slow-growing or fastidious organisms may not produce reliable results within standard incubation periods. Additionally, biochemical databases may not include recently described species or uncommon variants.

The WHO Laboratory Quality Management System Handbook emphasizes that all identification methods require validation and ongoing quality monitoring. Laboratories should establish acceptable performance criteria for biochemical tests and investigate any unexpected results.

MALDI-TOF Mass Spectrometry

Principles of MALDI-TOF MS Identification

Matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) has transformed clinical microbiology by providing rapid, accurate microbial identification. The technology generates mass spectra from ribosomal proteins and other abundant cellular proteins, creating a protein fingerprint characteristic of each species.

During analysis, a small amount of microbial biomass is placed on a target plate and covered with a matrix solution. The laser ionizes the sample, and the time-of-flight detector measures the mass-to-charge ratios of the resulting ions. The generated spectrum is compared against a reference database to determine the most likely species match.

MALDI-TOF MS is rapid, sensitive, and economical in terms of both labor and costs involved. The technology has been adopted for microbial identification and strain typing, epidemiological studies, detection of biological warfare agents, detection of water and food-borne pathogens, detection of antibiotic resistance, and detection of blood and urinary tract pathogens. The limitation of the technology is that identification of new isolates is possible only if the spectral database contains peptide mass fingerprints of the type strains of specific genera, species, subspecies, or strains.

Workflow Integration

MALDI-TOF MS requires isolated colonies grown on culture media. The workflow involves colony selection, sample application to the target plate, matrix addition, and instrument analysis. Results are typically available within minutes of sample preparation.

Direct identification from positive blood culture bottles is possible using short preparation protocols. One study evaluated a 30-minute protocol using Triton X, SDS, and saponin for direct identification of pathogens from positive blood culture bottles. The agreement of Triton X, SDS, and saponin direct identification methods compared to the conventional method was 96.2%, 91.8%, and 90% respectively. This approach significantly reduces turnaround time for bloodstream infection diagnosis.

Database Considerations

The accuracy of MALDI-TOF MS identification depends heavily on the quality and completeness of the reference database. Organisms not represented in the database will not be identified correctly, and closely related species may be difficult to distinguish if their spectral profiles are similar.

Laboratories should maintain current database versions and consider supplementing with locally generated spectra for clinically relevant organisms. Regular quality control testing with reference strains verifies instrument performance and database accuracy.

Advanced MALDI-TOF Applications

Beyond routine species identification, MALDI-TOF MS is being explored for subspecies-level discrimination and antimicrobial resistance detection. Machine learning techniques applied to MALDI-TOF mass spectra have shown promise for refining species identification and streamlining antimicrobial resistance determination. Support Vector Machines, Genetic Algorithms, Artificial Neural Networks, and Quick Classifiers are among the algorithms used in these applications.

Lipid profiling using linear negative-ion mode MALDI-TOF MS offers complementary information to conventional protein-based systems. A study evaluating five lipid pretreatment methods found that sodium acetate buffer provided a favorable balance between operational feasibility, extraction efficiency, and spectral quality. Lipid profiles generated from 203 bacterial strains representing six species revealed distinct species-specific lipid fingerprints. A lipid fingerprint database validated using an independent set of 144 strains achieved identification accuracies of 81.9% at the species level and 97.2% at the genus level.

Molecular Methods: 16S rRNA Gene Sequencing

Principles of 16S rRNA Analysis

The 16S rRNA gene is present in all bacteria and contains conserved and variable regions that enable phylogenetic classification. Sequencing this gene provides a molecular basis for species identification that is independent of phenotypic expression.

The workflow involves DNA extraction, PCR amplification of the 16S rRNA gene, sequencing, and comparison of the resulting sequence against reference databases. Full-length 16S rRNA amplicon sequencing provides higher resolution than partial sequencing and can detect species missed by culture-based methods.

A study comparing MALDI-TOF MS identification and PacBio full-length 16S rRNA and ITS sequencing for spoilage microbial communities found that full-length 16S rRNA sequencing provided higher resolution, detecting species missed by culturing methods, including psychrotrophic and fastidious lactic acid bacteria. This demonstrates the value of molecular methods for comprehensive community analysis.

Sequencing Workflow Considerations

DNA extraction quality significantly affects sequencing success. Laboratories should use validated extraction methods appropriate for the organism types being analyzed. Gram-positive organisms require more robust cell lysis than Gram-negative organisms.

PCR amplification requires careful primer selection and optimization. The 16S rRNA gene is approximately 1,500 base pairs, and full-length sequencing provides maximum phylogenetic resolution. However, some laboratories use shorter variable region amplicons for cost savings, accepting reduced resolution.

Bioinformatics analysis involves quality filtering, sequence assembly, and database comparison. The National Center for Biotechnology Information provides literature resources and databases for sequence analysis. The quality of automated gene prediction in microbial organisms has improved steadily, with algorithms like Prodigal focusing on improved gene structure prediction, improved translation initiation site recognition, and reduced false positives.

Applications in Probiotic and Product Testing

Full-length 16S rRNA amplicon sequencing has been developed for species-level identification of probiotics in commercial products. Studies have consistently reported discrepancies between labeling and actual microbial composition. An optimized sequencing workflow using Q10 filtering, the Emu pipeline with its default database, and a 0.1% relative abundance threshold enabled comprehensive species-level identification of probiotics within a single assay. Application to eight probiotic products revealed that approximately 50% showed labeling discrepancies with some labeled strains undetected.

This application demonstrates the utility of molecular identification for quality control and labeling verification in commercial products.

Advanced Molecular and Computational Approaches

Whole Genome Sequencing and Pan-Genome Analysis

Whole genome sequencing provides the highest resolution for microbial identification and strain characterization. Computational pan-genome analysis has emerged from the rapid increase of available genome sequencing data. Characterizing a pan-genome provides insights into intra-species evolution, functions, and diversity.

Researchers face challenges such as processing and maintaining large datasets while providing accurate and efficient analysis approaches. Comparative genomics methods are required for detecting conserved and unique regions between sets of genomes. Tools for pan-genome analysis are categorized into gene-based and sequence-based groups according to the pan-genome identification method.

Strain-Level Identification

Microbial strains are interpreted as lineages derived from recent ancestors that have not experienced too many recombination events and can be successfully retrieved with culture-independent techniques using metagenomic sequencing. Strain variability has been increasingly shown to display additional phenotypic heterogeneities that affect host health, such as virulence, transmissibility, and antibiotic resistance.

Statistical and computational methods have been developed to track strains in samples based on shotgun metagenomics data, either based on reference genome sequences or metagenome-assembled genomes. These methods differ in terms of whether reference genome sequences are needed, how single nucleotide variants are called, what methods of deconvolution are used, and whether the methods can be applied to multiple samples.

Emerging Spectroscopic and Sensor Technologies

Raman spectroscopy provides a label-free and noninvasive technique that offers rich chemical information for fast microbial diagnoses. A Combined Mutual Learning Net demonstrated an average identification accuracy of 87.96% in an open-access dataset with thirty microbial strains, representing a 5.76% improvement over existing methods. The method achieved a subspecies accuracy of 92.4% in a custom-built fiber-optical tweezers Raman spectroscopy system that collects spectra at a single-cell level.

Electronic nose technology using metal-oxide sensors has been investigated for identifying bacterial cultures grown under biofilm-promoting conditions. Classification accuracy reached at most 55.6% when considering all five classes, with Shapley-based interpretation attributing the limitations mainly to biological factors. Accuracy increased to 100.0% for species with distinct volatile signatures. These findings demonstrate that classification performance in biological sensing cannot be explained solely by algorithmic factors.

Cell-Free DNA Detection

Microbial cell-free DNA enables rapid and sensitive pathogen detection via direct plasma sequencing. A fast, cost-effective multiplex workflow was developed to complement or improve the sensitivity of microbiological diagnostics for systemic and focal infections that can be challenged by prior antibiotic treatment or non-culturable pathogens. In an explorative study of 18 patients, microbial cell-free DNA sequencing matched the clinical diagnosis in 16 cases (89%), was detected up to 16 days after starting targeted antibiotic therapy, and identified Staphylococcus aureus in two cases of culture-negative endocarditis.

Method Selection Framework

Laboratory Resource Assessment

Selecting an identification method requires honest assessment of laboratory resources. Key considerations include available equipment, technical expertise, sample volume, budget constraints, and clinical requirements. Laboratories should evaluate both initial capital costs and ongoing operational expenses.

The WHO Laboratory Quality Management System Handbook provides a framework for implementing quality systems that support reliable identification results. Laboratories should document their method selection rationale and regularly review whether chosen methods continue to meet clinical needs.

Clinical Context Considerations

The clinical context influences method selection. Bloodstream infections require rapid identification to guide antimicrobial therapy. A study evaluating direct microbial identification by MALDI-TOF MS and antimicrobial susceptibility testing for early diagnosis of bloodstream infections found that direct methods are both time and cost effective. The study tested 960 pathogen and antimicrobial agent combinations, with 99.8% of antimicrobial sensitivity testing results by the direct method showing categorical agreement with the standard routine disc diffusion method.

For pediatric osteoarticular infections, blood culture bottle systems improved microbial identification rates compared to conventional swab and tissue culture methods. The microbial identification rate was higher with blood culture bottles (68%) than with swab cultures (45%) or tissue cultures (38%). Blood culture bottles also reduced the time required for identification.

Resource-Limited Settings

Resource-limited settings require identification methods that balance accuracy with affordability. Automated microbial identification and antimicrobial susceptibility testing systems can enable early microbial identification within 8 hours of positive flagging of blood culture bottles. A direct inoculum protocol using a commercial automated system correctly identified 94% of Gram-negative organisms compared to the standard inoculum preparation protocol.

The WHO Laboratory Biosafety Manual provides guidance for laboratories operating with limited resources, emphasizing risk assessment and appropriate containment practices.

Quality Control and Assurance

Internal Quality Control

Each identification method requires appropriate quality control procedures. For biochemical tests, laboratories should test reference strains with known reactions to verify reagent performance. For MALDI-TOF MS, calibration standards and reference strains verify instrument accuracy. For molecular methods, positive and negative controls monitor amplification and sequencing performance.

The WHO Laboratory Quality Management System Handbook emphasizes the importance of documented quality control procedures and corrective action when results fall outside acceptable ranges.

External Quality Assessment

Participation in external quality assessment programs provides independent verification of identification accuracy. These programs distribute unknown specimens that laboratories must identify using their routine methods. Results are compared across participating laboratories to identify systematic errors.

Laboratories should review external quality assessment results and implement corrective actions when discrepancies are identified.

Documentation Requirements

Accurate documentation is essential for quality assurance and patient safety. Records should include specimen information, culture results, identification method used, final identification, and any discrepancies or unusual findings. Documentation should be complete enough to allow result verification and audit.

The WHO Laboratory Quality Management System Handbook provides guidance on record keeping requirements and document control.

Common Failure Patterns and Troubleshooting

Phenotypic Method Failures

Biochemical identification failures often result from impure cultures, incorrect incubation conditions, or database limitations. Mixed cultures produce ambiguous reaction profiles that may not match any database entry. Laboratories should verify culture purity before performing biochemical tests.

Atypical biochemical reactions can occur due to phenotypic variability, plasmid-mediated traits, or unusual strains. When biochemical results are inconsistent with colony morphology or Gram stain findings, laboratories should repeat testing or proceed to molecular methods.

MALDI-TOF MS Failures

MALDI-TOF MS identification failures typically result from insufficient biomass, improper sample preparation, or database gaps. Organisms not represented in the database will not be identified, and closely related species may be misidentified if their spectral profiles are similar.

Sample preparation errors include inadequate matrix application, excessive or insufficient bacterial biomass, and contamination. Laboratories should follow manufacturer recommendations for sample preparation and maintain the instrument according to specifications.

Molecular Method Failures

Molecular identification failures can result from DNA extraction problems, PCR inhibition, sequencing errors, or database mismatches. PCR inhibitors in clinical specimens can prevent amplification. Laboratories should use appropriate extraction methods and include inhibition controls.

Sequence analysis failures may result from poor quality sequences, chimeric sequences, or incomplete reference databases. Laboratories should use quality filtering and validate results against multiple databases when possible.

Biosafety and Regulatory Considerations

Biosafety Practices

Microbial identification procedures involve handling potentially hazardous microorganisms. The WHO Laboratory Biosafety Manual provides comprehensive guidance on safe laboratory practices, containment equipment, and facility design. Laboratories should conduct risk assessments for the organisms they handle and implement appropriate biosafety levels.

Standard precautions include hand hygiene, personal protective equipment, and safe handling of sharps. Centrifugation of clinical specimens requires sealed rotors and safety buckets. Procedures that generate aerosols require additional containment measures.

Regulatory Requirements

Diagnostic laboratories must comply with applicable regulations and accreditation standards. The U.S. Food and Drug Administration provides guidance on bioanalytical method validation that is relevant to laboratories developing or modifying identification methods. The National Center for Advancing Translational Sciences provides the Assay Guidance Manual for developing and validating assays.

Laboratories should maintain current knowledge of regulatory requirements and ensure that identification methods meet applicable standards for clinical use.

Professional Escalation Criteria

Laboratories should establish clear criteria for escalating identification challenges to supervisors, reference laboratories, or specialized consultants. Escalation is appropriate when:

• Identification results are inconsistent with clinical presentation
• Unusual or rare organisms are suspected
• Identification failures persist after troubleshooting
• Results have significant implications for patient management
• Outbreak investigations require strain-level characterization

Reference laboratories can provide specialized testing including whole genome sequencing, advanced serotyping, or antimicrobial resistance characterization. The National Center for Biotechnology Information provides literature resources and databases that support advanced identification and characterization.

Records and Measurements

Laboratories should maintain comprehensive records of identification activities. Essential records include:

• Specimen receipt and accession information
• Culture results and colony morphology descriptions
• Gram stain findings
• Biochemical test results
• MALDI-TOF MS spectra and database matches
• Sequencing results and analysis parameters
• Quality control results
• Corrective actions and resolutions

Turnaround time measurements help laboratories monitor performance and identify bottlenecks. Laboratories should track time from specimen receipt to final identification and compare performance against established targets.

Common Failure Patterns in Workflow Integration

Disconnected Workflow Steps

Laboratories sometimes treat identification methods as isolated procedures instead of integrated workflow components. This disconnection leads to redundant testing, delayed results, and missed opportunities for efficiency. Laboratories should design workflows that logically progress from initial assessment to definitive identification.

Inadequate Database Maintenance

Both MALDI-TOF MS and sequencing identification depend on current, comprehensive databases. Laboratories that neglect database updates risk misidentification or failure to identify emerging pathogens. Regular database maintenance should be scheduled and documented.

Insufficient Staff Training

Identification methods require specialized skills for optimal performance. Laboratories should provide initial training and ongoing competency assessment for all staff performing identification procedures. Cross-training ensures continuity when primary staff are unavailable.

Limitations of Current Methods

Phenotypic Method Limitations

Phenotypic methods cannot identify organisms that fail to grow in culture, grow slowly, or exhibit atypical reactions. Some organisms require specialized media or growth conditions that are not available in routine laboratories. Phenotypic variability within species can lead to misidentification.

MALDI-TOF MS Limitations

MALDI-TOF MS cannot identify organisms that are not represented in the reference database. Closely related species may have similar spectral profiles that prevent reliable discrimination. The technology requires isolated colonies, adding time for culture growth.

Sequencing Limitations

16S rRNA gene sequencing has limited resolution for some closely related species that share nearly identical 16S rRNA sequences. The method requires significant technical expertise and bioinformatics support. Sequencing results may be ambiguous when reference databases contain incomplete or incorrect entries.

Emerging Technology Limitations

Emerging technologies including Raman spectroscopy, electronic noses, and cell-free DNA detection are promising but require further validation for routine clinical use. A study of electronic nose technology found that classification performance was influenced by biological factors including signal similarity to control samples and inter-day variability. These limitations must be addressed before widespread clinical adoption.

Safety Context for Laboratory Workers

Laboratory workers face potential exposure to pathogenic microorganisms during identification procedures. The WHO Laboratory Biosafety Manual provides guidance on risk assessment, containment, and safe work practices. Key safety considerations include:

• Handling of clinical specimens and cultures
• Aerosol generation during centrifugation and vortexing
• Sharps injuries during specimen processing
• Chemical hazards from staining reagents and buffers
• Electrical and laser hazards from laboratory equipment

Laboratories should provide appropriate training, personal protective equipment, and emergency procedures. Occupational health programs should include vaccination recommendations and exposure management protocols.

Frequently Asked Questions

What is the fastest method for microbial identification?

MALDI-TOF MS provides the fastest identification from isolated colonies, with results available within minutes after sample preparation. Direct identification from positive blood culture bottles is possible using short preparation protocols, with one study demonstrating a 30-minute protocol using Triton X, SDS, and saponin. However, culture growth is still required before MALDI-TOF MS analysis can be performed.

When should 16S rRNA sequencing be used instead of biochemical tests?

16S rRNA sequencing should be used when biochemical tests produce ambiguous results, when organisms are difficult to identify by phenotypic methods, when novel or unusual organisms are suspected, and when species-level identification is required for organisms with limited biochemical databases. Sequencing also identifies organisms that fail to grow in culture when applied to clinical specimens directly.

How accurate is MALDI-TOF MS compared to biochemical identification?

MALDI-TOF MS generally provides more accurate species-level identification than biochemical methods for organisms represented in its reference database. The technology is rapid, sensitive, and economical in terms of both labor and costs involved. However, identification accuracy depends on database quality, and organisms not represented in the database will not be identified correctly.

Can MALDI-TOF MS distinguish between closely related species?

MALDI-TOF MS can distinguish many closely related species, but resolution depends on the spectral differences between species and the quality of the reference database. Some closely related species have similar protein profiles that make discrimination difficult. Advanced applications using lipid profiling or machine learning algorithms may improve subspecies-level discrimination.

What are the main limitations of biochemical identification methods?

Biochemical identification is limited by phenotypic variability within species, overlapping reaction profiles between species, and the need for pure cultures. Some organisms grow slowly or fail to grow under standard conditions, preventing biochemical testing. Databases may not include recently described species or uncommon variants.

How should laboratories choose between different identification methods?

Laboratories should assess their sample volume, budget, technical expertise, and clinical requirements. High-volume laboratories may benefit from MALDI-TOF MS despite the initial instrument investment. Low-volume laboratories may find biochemical panels more cost-effective. Reference laboratories may require sequencing capabilities for comprehensive identification.

What quality control measures are needed for microbial identification?

Quality control measures include testing reference strains with known characteristics, verifying reagent and instrument performance, participating in external quality assessment programs, and maintaining comprehensive documentation. The WHO Laboratory Quality Management System Handbook provides guidance on implementing quality systems for diagnostic laboratories.

When should specimens be referred to a reference laboratory?

Specimens should be referred when identification results are inconsistent with clinical presentation, when unusual or rare organisms are suspected, when identification failures persist after troubleshooting, or when strain-level characterization is needed for outbreak investigations. Reference laboratories can provide specialized testing including whole genome sequencing and advanced antimicrobial resistance characterization.

Related Diagnostic Guides

• MALDI-TOF Mass Spectrometry for Veterinary Microbial Identification
• How to Interpret Gram Stain Results: Morphology, Arrangement, and Color
• Thermometer Calibration for Laboratory Use: Ice Point and Comparison Methods
• Biochemical Test Comparison: Catalase, Oxidase, and Coagulase for Bacterial Identification
• Microbiology Plating Techniques: Streak, Spread, Pour, and Drop Methods Compared

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• Prodigal: prokaryotic gene recognition and translation initiation site identification.. BMC bioinformatics, 2010.
• Statistical and Computational Methods for Microbial Strain Analysis.. Methods in molecular biology (Clifton, N.J.), 2023.
• Evaluation of lipid pretreatment methods for microbial identification using linear negative-ion MALDI-TOF MS.. Journal of microbiological methods, 2026.
• Identification of Microbial Strains via 2D Cross-Correlation of LC-MS Data.. Journal of the American Society for Mass Spectrometry, 2024.
• Combined Mutual Learning Net for Raman Spectral Microbial Strain Identification.. Analytical chemistry, 2024.
• Direct Microbial Identification using An Automated Microbial Identification System to Facilitate the EUCAST RAST Method Without Mass Spectrometry.. Journal of visualized experiments : JoVE, 2024.
• Effective and Rapid Microbial Identification in Pediatric Osteoarticular Infections Using Blood Culture Bottles.. The Journal of bone and joint surgery. American volume, 2020.
• Pan-Genome Storage and Analysis Techniques.. Methods in molecular biology (Clifton, N.J.), 2018.
• Full-Length 16S rRNA Amplicon Sequencing for the Simple and Simultaneous Detection of Multiple Probiotic Species in Commercial Products.. 2026.
• Microbial cell-free DNA for rapid pathogen identification in clinical diagnostics: a proof of concept study.. 2026.
• Data-driven exploration of electronic nose technology to differentiate bacteria in blood cultures under biofilm-promoting conditions.. 2026.
• MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Frontiers in Microbiology, 2015.
• Antifungal susceptibilities and identification of Candida species by using maldi-tof microbial identification system from cervicovaginal samples. 2017.
• Machine learning for microbial identification and antimicrobial susceptibility testing on MALDI-TOF mass spectra: a systematic review.. Clinical Microbiology and Infection, 2020.
• Assessment of spoilage microbial communities in modified atmosphere-packed ready-to-eat salad during cold storage: A comparative study using MALDI-TOF MS identification and PacBio full-length 16S rRNA and ITS sequencing.. Journal of food microbiology, 2025.
• Evaluation of direct microbial identification by MALDI-TOF MS and antimicrobial susceptibility testing for early diagnosis of blood stream infections. BMC Microbiology, 2025.
• Rapid identification of microbial contaminants in pharmaceutical products using a PCA/LDA-based FTIR-ATR method. Brazilian Journal of Pharmaceutical Sciences, 2021.
• Microbial identification in endodontic infections with an emphasis on molecular diagnostic methods: A review. Iioab Journal, 2016.
• Microbial identification in the pharmaceutical industry. Pharmacopeial Forum, 2004.
• Novel computational methods in anti-microbial target identification. Drug Discovery Today, 2001.
• Identification of keystone taxa in rhizosphere microbial communities using different methods and their effects on compounds of the host Cinnamomum migao. Science of the Total Environment, 2024.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.